News | July 08, 2007

Medtronic Launches Wireless ICDs in Japan

July 9, 2007 - Medtronic Inc. announced the commercial launch of its latest cardiac resynchronization therapy-defibrillator, the Concerto CRT-D, and its latest implantable cardioverter-defibrillator, the Virtuoso ICD, which are the first of their kind in the Japanese market.
The CRT-D devices are equipped with the functions of an ICD, while also providing cardiac resychronization therapy for patients suffering from heart failure. The Concerto and Virtuoso are the first devices in Japan with wireless functionality, designed to reduce follow-up and procedure times.
The implanted devices internally record the patient’s pulse, device therapies delivered and other data over a certain period of time. This information is then provide this information wirelessly. Device settings can also be performed using the wireless function.
The Concerto and Virtuoso deliver anti-tachycardia pacing (ATP), while simultaneously charging the capacitor to provide a shock, if needed. This means that if the arrhythmia is not terminated using ATP, the devices are able to deliver the electrical shock with no delay, giving patients access to the safe, painless ATP therapy while minimizing patient burden.
The Concerto and Virtuoso are also reportedly the first devices in Japan capable of measuring the impedance in the thoracic cavity between the device implanted below the clavicle and the lead implanted in the ventricle, allowing the device to record the level of fluid in the patient’s lungs.

For more information:

Related Content

Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD)| July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation| July 03, 2017
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in...
Sponsored Content | Videos | Cardiovascular Ultrasound| June 29, 2017
Leyla Elif Sade, M.D., MESC, professor of cardiology at Başkent University, Ankara, Turkey, discusses use of echo for
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Sponsored Content | Videos | Implantable Cardioverter Defibrillator (ICD)| June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Sponsored Content | Videos | Leads Implantable Devices| May 25, 2017
Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancemen
Overlay Init